Cellebrite

Cybersecurity Public company Dual-Use Technology Founded 1999

Last updated: Jul 31, 2026

Cellebrite is a public digital-investigative software and services company whose platform helps public-safety, government, defense, intelligence, and enterprise teams lawfully collect, examine, analyze, and manage digital evidence.

Visit Website

Company Overview

Cellebrite is a mature digital-investigative software and services company built around legally sanctioned evidence workflows. Its portfolio spans field collection and extraction, examination and review, analytics, evidence management, reporting, training, and advanced services. The company presents this as a case-to-closure or digital-investigation platform rather than as a single device-unlocking product. That distinction matters: a customer’s operational problem is to turn heterogeneous data from phones, computers, cloud services, applications, and open sources into defensible investigative findings while preserving provenance, access controls, auditability, and chain of custody. The platform therefore sits between difficult data access and case-ready intelligence.

The technology is difficult to maintain because the underlying environment changes continuously. iOS and Android releases, secure enclaves, encryption, authentication changes, application updates, cloud APIs, messaging formats, and anti-forensic behavior can all affect what can be collected and how it must be validated. Cellebrite must combine device and cloud acquisition research, parsers for rapidly changing artifacts, scalable processing, search and link analysis, selective extraction, permissions, hashing, and reporting. Its current platform messaging also emphasizes AI-assisted investigation and hybrid deployment, but the durable moat is likely the accumulated research, validation, training, workflow integration, and installed-base knowledge required to keep evidence usable after each platform change.

Commercially, the company sells to public-safety agencies, federal and other government users, defense and intelligence organizations, and enterprises handling internal investigations, fraud, compliance, or eDiscovery. Cellebrite says its solutions have been used in more than five million investigations and that it serves thousands of public and private customers; its 2025 annual report describes more than 1.5 million legally sanctioned investigations annually. These are company-reported traction signals rather than independent validation, but they indicate a substantial installed base and recurring operational dependence. Government procurement, renewals, training, services, and expansion from collection into broader analytics and evidence management are central commercial variables. Public-sector concentration can support high switching costs while also creating exposure to budget cycles, procurement rules, and policy scrutiny.

Competition includes MSAB, Magnet Forensics, Oxygen Forensics, Grayshift, OpenText EnCase, and adjacent eDiscovery, endpoint, cloud-forensics, and investigative-analytics products. Customers compare extraction breadth, time to actionable insight, artifact accuracy, supported devices and applications, deployment model, integrations, training, courtroom defensibility, and total cost. Cellebrite’s edge is the combination of broad collection coverage, a large workflow and services footprint, recognized training, and the ability to connect field, laboratory, analyst, and management processes. That advantage is not permanent: a major operating-system change, a competitor’s acquisition, or a successful open-source and specialist-tool workflow could narrow the gap.

The dual-use case is substantive but bounded by lawful authority and customer governance. Corporate fraud and insider-threat investigations use the same collection, parsing, timeline, and collaboration capabilities that can support criminal investigations, counter-terrorism, border-security, military intelligence, or incident response involving seized or voluntarily supplied devices. This is strategically relevant infrastructure for allied investigative capacity, not evidence that every customer or use is military. The principal diligence questions are whether access techniques remain effective, whether outputs are forensically reliable, how customers control authorization and retention, and how the company handles allegations of misuse or sales into high-risk jurisdictions. Cellebrite is therefore best classified as a mature public-company reference asset with real security adjacency, not as a venture-stage startup.

Dual-Use Assessment

Military & Commercial Applications

Cellebrite has substantive dual-use applicability: the same lawful collection, extraction, analysis, and evidence-management capabilities serve enterprise investigations and public-sector criminal, intelligence, defense, border-security, and incident-response workflows. The defense relevance is real but depends on legal authorization, customer controls, jurisdiction, and the specific mission; it should not be conflated with proof of military procurement.

Strategic Fit Assessment

Cellebrite has credible technology depth, recurring workflow relevance, and clear security adjacency, but it is a mature Nasdaq-listed company rather than an independent startup. The legacy flag remains false because this database is intended to surface startup priorities; public-market valuation, policy exposure, and a different diligence framework also make it inappropriate to treat this record as an investment recommendation.

Strategic Value to U.S.-Israel Alliance

Cellebrite is strategically relevant as digital-investigation infrastructure for public safety, allied security, and enterprise investigations. Its installed base, research capability, training ecosystem, and evidence workflow integration can strengthen investigative capacity, while its access capabilities and customer reach make governance, lawful-use controls, export compliance, and human-rights diligence material to any strategic relationship.

Key Technologies

  • Mobile-device acquisition, lawful extraction, and advanced device access
  • Cloud, computer, application, and open-source evidence collection
  • Forensic artifact parsing, validation, search, and timeline reconstruction
  • AI-assisted investigative analytics, link analysis, and triage
  • Case-centric digital-evidence management with permissions, hashing, and audit trails
  • Secure on-premises, cloud, and hybrid investigative workflows
  • Forensic training, technical support, and advanced lawful-access services

Use Cases & Applications

  • Law-enforcement collection and analysis of mobile, computer, and cloud evidence
  • Counter-terrorism, organized-crime, trafficking, and child-exploitation investigations
  • Border-security and homeland-security examination of lawfully seized devices
  • Defense and intelligence exploitation of captured or voluntarily supplied digital devices
  • Corporate investigations of fraud, insider threat, misconduct, and policy violations
  • Financial-crime and anti-fraud reconstruction of communications and activity timelines
  • Regulated-enterprise eDiscovery and defensible evidence preservation
  • Incident response and investigative collaboration across distributed teams

Sources and verification

This profile is based on public-source research, Claw & Talon curation, and editorial judgment. Inclusion does not imply endorsement, partnership, investment, or a recommendation to transact. Readers should still confirm current status, customers, funding, and product claims before relying on this profile. The editorial policy explains how profiles are researched, where automated drafting is used, and how corrections work.

This record lists 6 public references used for company identity, status, positioning, or material-claim review.

Public sources

The links below are visible public references used for source discipline around company identity, status, funding, customer, acquisition, public-company, or other material claims where available.

Investor Lens

What this entry is

Public company

Why it may matter

Cellebrite may matter as a Cybersecurity entry with public-market context for Israeli technology research.

How an independent investor should read this

Public-market context. Read this profile as a starting point for independent verification, not as a recommendation or suitability assessment.

Evidence to verify

  • Verify current status
  • Verify technical claims
  • Verify regulatory/export-control issues

Main investor questions

  • What part of revenue, risk, valuation, and strategy is actually tied to Israeli technology themes?
  • Which public filings, liquidity, and valuation assumptions matter most?
  • Does the dual-use claim map to actual commercial and government/defense/resilience buyer evidence?
  • What evidence would change the thesis or show that the profile is stale?

What not to infer

  • Inclusion does not imply endorsement.
  • Inclusion does not imply allocation availability or current fundraising.
  • Scores do not indicate investment suitability or expected returns.
  • Strategic importance does not automatically imply venture return potential.

Diligence questions

  • What evidence verifies Cellebrite's current customer traction, deployment status, and revenue concentration?
  • Which technical claims are independently demonstrable today, and which remain roadmap or pilot-stage assertions?
  • Where does the product create real defense, intelligence, critical-infrastructure, or emergency-response value beyond ordinary commercial adoption?
  • How does the platform integrate into existing SOC, cloud, identity, or compliance workflows without adding operational burden?
  • Is the company a live venture opportunity, a mature strategic reference, an acquired asset, or primarily a market-mapping entry?

Related sector

See the Cybersecurity sector page for market context, related subcategories, and other Israeli companies in this part of the database.

Need a diligence readout?

Use the profile and related checklists as a starting point. If the decision needs more context, request a company screen, founder-call prep, diligence memo, or sector readout.